Trending...
- Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
- Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
- Atlanta Magazine Names Dr. Rashad Richey One of Atlanta's Most Influential Leaders in 2026 as the FIFA World Cup Approaches
The study aims to validate KollaJell™ as the first and only collagen-based brain health product backed by clinical trials.
TEMECULA, Calif. - ncarol.com -- Temecula, CA—Certified Nutraceuticals Inc. announced the start of a clinical study on the cognitive benefits of KollaJell™, a patented jellyfish collagen supplement uniquely formulated to support brain health. The study aims to validate KollaJell™ as the first and only collagen-based brain health product backed by clinical trials.
The innovative study will utilize advanced brain imaging technologies, including electroencephalographic (EEG) scans, to measure cognitive function and brain activity before and after KollaJell™ supplementation. The project also utilizes computerized cognitive assessments to evaluate critical mental performance domains such as memory and multitasking. Results of this unique investigation are anticipated by April 2025 and will be published in peer-reviewed scientific journals.
The research team consists of Dr. G.M. Haase, who has developed numerous innovations in nutritional science, holds 12 U.S. patents, and has published 200 research papers. Neil Wolkodoff, Ph.D., is the Medical Program Director of the Colorado Center for Health and Sport Science and is an expert in health and performance metrics.
More on ncarol.com
Abdul Alkayali, Senior Vice President of Certified Nutraceuticals noted, "CN has been at the forefront of nutritional innovation, with KollaJell™ standing as a testament to our commitment to science-backed health solutions. This clinical study represents a significant step toward establishing KollaJell™ as the only brain health supplement with academic-led clinical validation. The study will solidify the product's credibility and enhance our global market presence."
About Certified Nutraceuticals
Certified Nutraceuticals develops natural, functional, ingredient-based compounds that promote healthy and active lifestyles. Products are rooted in traditional medicine and validated by modern science and impact anti-aging on a cellular level, joint, brain, cardiovascular, and immune health.
Learn more at www.certifiednutra.com
Media Contact: Sara Alkayali, 951-600-3899. Email: salkayali@certifiednutra.com
The innovative study will utilize advanced brain imaging technologies, including electroencephalographic (EEG) scans, to measure cognitive function and brain activity before and after KollaJell™ supplementation. The project also utilizes computerized cognitive assessments to evaluate critical mental performance domains such as memory and multitasking. Results of this unique investigation are anticipated by April 2025 and will be published in peer-reviewed scientific journals.
The research team consists of Dr. G.M. Haase, who has developed numerous innovations in nutritional science, holds 12 U.S. patents, and has published 200 research papers. Neil Wolkodoff, Ph.D., is the Medical Program Director of the Colorado Center for Health and Sport Science and is an expert in health and performance metrics.
More on ncarol.com
- Ice Melts. Clean Water Fails. A Startup Thinks It Has the Fix
- Delay In Federal Disaster Assistance Causing Failure Of Small Business In Disaster Areas
- Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
- When Representation No Longer Reflects the District — Why I'm Voting for Pete Verbica
- Off The Hook YS (NY SE: OTH) Executes Transformational Apex Acquisition, Creating Vertically Integrated Marine Powerhouse with $60M Inventory Capacity
Abdul Alkayali, Senior Vice President of Certified Nutraceuticals noted, "CN has been at the forefront of nutritional innovation, with KollaJell™ standing as a testament to our commitment to science-backed health solutions. This clinical study represents a significant step toward establishing KollaJell™ as the only brain health supplement with academic-led clinical validation. The study will solidify the product's credibility and enhance our global market presence."
About Certified Nutraceuticals
Certified Nutraceuticals develops natural, functional, ingredient-based compounds that promote healthy and active lifestyles. Products are rooted in traditional medicine and validated by modern science and impact anti-aging on a cellular level, joint, brain, cardiovascular, and immune health.
Learn more at www.certifiednutra.com
Media Contact: Sara Alkayali, 951-600-3899. Email: salkayali@certifiednutra.com
Source: Certified Nutraceuticals
0 Comments
Latest on ncarol.com
- Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy
- $36 Million LOI to Acquire High Value Assets from Vivakor Inc in Oklahoma's STACK Play — Building Cash Flow and Scalable Power Infrastructure; $OLOX
- Kobie Wins for AI Innovations in the 2026 Stevie® Awards for Sales & Customer Service
- Berman | Sobin | Gross LLP Celebrates 35 Years of Advocating for Maryland's Injured Workers and Families
- Art of Whiskey Hosts 3rd Annual San Francisco Tasting Experience During Super Bowl Week
- PADT Earns Prestigious 2025 Americas Customer Loyalty Award from Ansys, Part of Synopsys
- Florida Keys Visitors Can Save 15 Percent With KeysCaribbean's Advanced Booking Discount
- Sleep Basil Unveils Revamped Natural Latex Mattress Collection Page for Cooler, Cleaner, Better-Aligned Sleep
- Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
- DASH Carolina RDU Sets the Pace in 2025 with Record-Breaking Sales and Team Excellence
- Wespor Business Launches AI Voice and Chat Agents to Help Triangle Small Businesses Capture Missed Leads
- America's Boating Club Ushers in New Board at Change of Watch
- FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
- $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)
- CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
- PRÝNCESS Builds Anticipation With "My Nerves" — A Girls-Girl Anthem
- Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
- From Sleepless Nights to Sold-Out Drops: Catch Phrase Poet's First Year Redefining Motivational Urban Apparel
- Cold. Clean. Anywhere. Meet FrostSkin
- How Specialized Game Development Services Are Powering the Next Wave of Interactive Entertainment
